Ariad wins EC marketing authorization; GenVec lays off staff

 @FierceBiotech: UPDATED: A long lineup of potential buyers crowds Onyx picture. Article | Follow @FierceBiotech

 @JohnCFierce: MannKind shoulders $160M in debt for PhIII inhaled-insulin gamble. Story | Follow @JohnCFierce

 @RyanMFierce: Celgene, others regenerate biotech Tengion's finances with $33.6M. Report | Follow @RyanMFierce

> The EC provided Ariad Pharmaceuticals ($ARIA) marketing authorization for Iclusig (ponatinib) as an orphan product for two indications. Release

> A few weeks after announcing a liquidation plan, GenVec has laid off most of its staff. SEC filing

> Merck ($MRK) has licensed access to one of Xencor's Fc engineering patents for a therapeutic monoclonal antibody. Release

Medical Device News

 @FierceMedDev: Zoll grabs Minnesota startup with FDA challenges. News | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: a look at a colon cancer test that could detect tumor cells before they take root. DxExtra | Follow @MarkHFierce

 @DamianFierce: Our latest industry voices piece: A Dx insider weighs in on the implications of SCOTUS' MYGN ruling. More | Follow @DamianFierce

 @MichaelGFierce: 'Bioadhesive' coating helps oral drugs deliver payload. Item | Follow @MichaelGFierce

> Roche buys blood diagnostics outfit for $220M. Story

> Sequenta raises $20M for cancer diagnostics. Report

> ArthroCare forks over $45M for sinus surgical tool company. News

Pharma News

 @FiercePharma: Will the new weight loss drugs ever prosper? The NYT ticks off the odds stacked against them: Article | Follow @FiercePharma

> Expect a long slog for diet drugs Qsymia, Belviq. Story

> Who's hiring in Big Pharma? Novartis, Roche, Sanofi top the list. More

> Is GlaxoSmithKline's China probe a harbinger of more? Report

Pharma Manufacturing News

 @CarlyHFierce: 160 of India's manufacturing facilities prepared for new EU regulations going into effect today. Item | Follow @CarlyHFierce

>  With Aspen deal, Merck finally able to shrink legacy Organon sites. Story

> Med Prep slapped with consent decree as FDA eyes compounders. More

> Glass particles once again trigger Fresenius Kabi recall. Article

> King Pharma settles for $2.2M after violating pharma emissions standards. Story

Biotech Research News

 @EmilyMFierce: Mouse models predict chemo treatment response in humans. Report | Follow @EmilyMFierce

> Texas A&M launches multimillion-dollar genomics research project. More

> Report: U.K. health body stifling stem cell research. News

> Nonprofit licenses MS mouse model to Biogen Idec to develop new therapies. Story

And Finally... Investigators at UCLA say they are prepping a stem cell therapy for sickle cell disease for clinical trials. Release

Suggested Articles

Journey Colab launches with $3 million from Apollo Projects to develop a pipeline of psychedelic compounds through a new development model.

Forma's lead asset, an IDH1 inhibitor, cleared cancer in one-third of patients with relapsed or refractory acute myeloid leukemia.

A type of white blood cell known as a granulocyte secretes growth factors that help axons of the central nervous system regenerate, researchers found.